Loading...

Loading...

Personalized mRNA Melanoma Cancer Vaccine Enters Phase 3 Trial
By MBN Staff - Tue, 04/30/2024 - 09:13
Breakthrough trials for mRNA-4157 (V940), spearheaded by the UCLH, offer hope in revolutionizing melanoma treatment.

Partnership Content

Cluster Automotriz Nuevo Leon